HOTH - Hoth Therapeutics announces sponsored research pact COVID-19 testing device
Hoth Therapeutics ([[HOTH]] -3.8%) has entered into a research agreement with the George Washington University, related to the development of an in vitro diagnostic device that allows immediate detection of SARS-CoV-2 via a mobile device.Nanohole array-based device utilizes plasmonic system designed for high sensitivity and specificity for detecting the SARS-CoV-2 virus.The company plans to start discussions with the FDA about the development plans for this in early 2021 to position the device for an emergency use authorization request.
For further details see:
Hoth Therapeutics announces sponsored research pact COVID-19 testing device